(Q39682371)

13 September 2017

title

Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies (English)

1 reference

13 September 2017

1 reference

1 reference

8

Shibo Jiang

1 reference

13 September 2017

1

Lanying Du

1 reference

13 September 2017

7

Yusen Zhou

1 reference

13 September 2017

Guangyu Zhao

2

1 reference

13 September 2017

Xiujuan Zhang

3

1 reference

13 September 2017

Zhonghua Liu

4

1 reference

13 September 2017

Hong Yu

5

1 reference

13 September 2017

Bo-Jian Zheng

6

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

Biochemical and Biophysical Research Communications

13 September 2017

published in

1 reference

13 September 2017

volume

397

1 reference

13 September 2017

issue

3

1 reference

13 September 2017

page(s)

580-585

1 reference

Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic

13 September 2017

cites work

1 reference

12 December 2020

Emergence and pandemic potential of swine-origin H1N1 influenza virus

1 reference

12 December 2020

Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice

1 reference

12 December 2020

Contributions of the avian influenza virus HA, NA, and M2 surface proteins to the induction of neutralizing antibodies and protective immunity

1 reference

12 December 2020

Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses.

1 reference

12 December 2020

Length requirements for membrane fusion of influenza virus hemagglutinin peptide linkers to transmembrane or fusion peptide domains.

1 reference

12 December 2020

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

1 reference

12 December 2020

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

1 reference

12 December 2020

Generation and characterization of an H5N1 avian influenza virus hemagglutinin glycoprotein pseudotyped lentivirus

1 reference

12 December 2020

Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses.

1 reference

12 December 2020

Neutralizing anti-influenza virus monoclonal antibodies: therapeutics and tools for discovery.

1 reference

12 December 2020

Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza

1 reference

12 December 2020

New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets

1 reference

12 December 2020

Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge

1 reference

12 December 2020

Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library.

1 reference

12 December 2020

Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein

1 reference

12 December 2020

Combination therapy using chimeric monoclonal antibodies protects mice from lethal H5N1 infection and prevents formation of escape mutants.

1 reference

12 December 2020

Analysis of hemagglutinin-mediated entry tropism of H5N1 avian influenza.

1 reference

12 December 2020

Heterosubtype neutralizing responses to influenza A (H5N1) viruses are mediated by antibodies to virus haemagglutinin

1 reference

12 December 2020

Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial

1 reference

12 December 2020

H5N1 influenza viruses: outbreaks and biological properties

1 reference

12 December 2020

DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice.

1 reference

12 December 2020

Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity

1 reference

12 December 2020

Human single-chain antibodies that neutralize homologous and heterologous strains and clades of influenza A virus subtype H5N1.

1 reference

12 December 2020

Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion

1 reference

12 December 2020

Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses

1 reference

12 December 2020

Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies

1 reference

12 December 2020

Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses

1 reference

12 December 2020

10.1016/J.BBRC.2010.05.161

Identifiers

DOI

1 reference

13 September 2017

0 references

1 reference